| (Rac)-Arnebin 1 |
|
|
|
99.88% |
| (Rac)-Dencichine |
|
|
|
|
| (Rac)-PT2399 |
|
|
|
99.84% |
| (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
|
|
|
98.62% |
| (S,R,S)-AHPC-C5-COOH |
|
|
|
98.81% |
| 1,4-DPCA |
|
|
|
99.78% |
| 1,4-DPCA ethyl ester |
|
|
|
99.48% |
| 1-Palmitoyl-2-oleoyl-sn-glycerol, 1-Oleoyl-3-palmitoylglycerol (1:1) |
|
|
|
97.23% |
| 103D5R |
|
|
|
|
| AKBA |
|
|
|
99.92% |
| 5,3',4',3'',4'',5''-6-O-Ethyl-EGCG |
|
|
|
|
| 7-Hydroxyneolamellarin A |
|
|
|
|
| Abi-DZ-1 |
|
|
|
|
| Acetylarenobufagin |
|
|
|
98.63% |
| Adaptaquin |
|
|
|
99.87% |
| AG01 |
|
|
|
95.10% |
| AJM 290 |
|
|
|
|
| AKB-6899 |
|
|
|
99.95% |
| ALDOA-IN-1 |
|
|
|
98.46% |
| Aminoflavone |
|
|
|
|
| Angiogenesis agent 1 |
|
|
|
99.39% |
| Anti-inflammatory agent 79 |
|
|
|
|
| Antiproliferative agent-57 |
|
|
|
|
| Arylsulfonamide 64B |
|
|
|
|
| Astragaloside II |
|
|
|
99.45% |
| AT-533 |
|
|
|
98.38% |
| Axl-IN-16 |
|
|
|
|
| BAY 87-2243 |
|
|
|
99.40% |
| Belzutifan |
|
|
|
99.62% |
| Bendazol |
|
|
|
99.60% |
| BNS |
|
|
|
96.17% |
| Casdatifan |
|
|
|
96.37% |
| Chloramphenicol/BSA |
|
|
|
|
| CHNQD-03301 |
|
|
|
|
| cis VH-298 |
|
|
|
99.96% |
| CL67 |
|
|
|
|
| CLB-016 |
|
|
|
|
| Cryptolepine |
|
|
|
|
| CTK7A |
|
|
|
|
| Cyclo(CKLIIF) TFA |
|
|
|
98.07% |
| cyclo(CLLFVY) |
|
|
|
99.37% |
| Cyclo(CRLLIF) |
|
|
|
|
| Cyclo(CRVIIF) |
|
|
|
|
| D-01 |
|
|
|
|
| Glucosamine-13C6 |
|
|
|
|
| Daprodustat |
|
|
|
99.91% |
| Davotifan |
|
|
|
99.26% |
| DDO-3055 |
|
|
|
99.64% |
| Desidustat |
|
|
|
99.10% |
| DHW-221 |
|
|
|
|
| Diethyl bipy55'DC |
|
|
|
98.79% |
| DM-NOFD |
|
|
|
99.81% |
| DMOG |
|
|
|
99.93% |
| DMOG |
|
|
|
|
| DS-1093a |
|
|
|
|
| DS44470011 |
|
|
|
|
| DS79540454 |
|
|
|
|
| DYB-03 |
|
|
|
99.49% |
| Echinomycin |
|
|
|
98.57% |
| EGFR-IN-192 |
|
|
|
|
| eIF3e-IN-1 |
|
|
|
|
| EL-102 |
|
|
|
99.44% |
| ELR510444 |
|
|
|
98.0% |
| Enarodustat |
|
|
|
99.94% |
| Enarodustat hydrochloride |
|
|
|
|
| ENMD-1198 |
|
|
|
98.48% |
| Erenapurstat |
|
|
|
99.67% |
| Etrinabdione |
|
|
|
99.16% |
| EZN-2968 |
|
|
|
|
| EZN-2968 sodium |
|
|
|
95.34% |
| EZN-2968 sodium scrambled negative control |
|
|
|
|
| FAM-DEALA-Hyp-YIPD |
|
|
|
99.39% |
| FAM-DEALA-Hyp-YIPMDDDFQLRSF-NH2 |
|
|
|
|
| FG-2216 |
|
|
|
99.46% |
| Fibrostatin A |
|
|
|
|
| Fibrostatin B |
|
|
|
|
| Fibrostatin C |
|
|
|
|
| Fibrostatin D |
|
|
|
|
| Fibrostatin E |
|
|
|
|
| Fibrostatin F |
|
|
|
|
| FM19G11 |
|
|
|
98.39% |
| Fraxinellone |
|
|
|
99.91% |
| GEM-5 |
|
|
|
|
| GN44028 |
|
|
|
99.60% |
| Gramicidin A |
|
|
|
96.94% |
| GSK360A |
|
|
|
99.9% |
| GW-405833 |
|
|
|
98.91% |
| GW405833 hydrochloride |
|
|
|
99.59% |
| HATC |
|
|
|
|
| HIF-1 alpha (556-574) |
|
|
|
99.37% |
| HIF-1 alpha (556-574) TFA |
|
|
|
|
| HIF-1 inhibitor-4 |
|
|
|
98.11% |
| HIF-1 inhibitor-5 |
|
|
|
|
| HIF-1/2α-IN-1 |
|
|
|
|
| HIF-1/2α-IN-2 |
|
|
|
99.55% |
| HIF-1/2α-IN-3 |
|
|
|
|
| HIF-1α-IN-10 |
|
|
|
|
| HIF-1α-IN-2 |
|
|
|
98.48% |
| HIF-1α-IN-2 hydrochloride |
|
|
|
98.08% |
| HIF-1α-IN-3 |
|
|
|
|
| HIF-1α-IN-4 |
|
|
|
99.95% |
| HIF-1α-IN-5 |
|
|
|
99.95% |
| HIF-1α-IN-6 |
|
|
|
|
| HIF-1α-IN-7 |
|
|
|
|
| HIF-1α-IN-8 |
|
|
|
|
| HIF-2α agonist 2 |
|
|
|
99.59% |
| HIF-2α agonist 3 |
|
|
|
|
| HIF-2α-IN-1 |
|
|
|
99.92% |
| HIF-2α-IN-10 |
|
|
|
|
| HIF-2α-IN-11 |
|
|
|
|
| HIF-2α-IN-12 |
|
|
|
|
| HIF-2α-IN-13 |
|
|
|
|
| HIF-2α-IN-14 |
|
|
|
|
| HIF-2α-IN-15 |
|
|
|
|
| HIF-2α-IN-16 |
|
|
|
|
| HIF-2α-IN-17 |
|
|
|
|
| HIF-2α-IN-18 |
|
|
|
|
| HIF-2α-IN-2 |
|
|
|
99.93% |
| HIF-2α-IN-3 |
|
|
|
99.89% |
| HIF-2α-IN-4 |
|
|
|
99.96% |
| HIF-2α-IN-5 |
|
|
|
|
| HIF-2α-IN-6 |
|
|
|
|
| HIF-2α-IN-9 |
|
|
|
|
| HIF-IN-1 |
|
|
|
98.00% |
| HIF-IN-2 |
|
|
|
95.0% |
| HIF-PHD-IN-1 |
|
|
|
98.84% |
| HIF-PHD-IN-2 |
|
|
|
|
| HIF-PHD-IN-4 |
|
|
|
|
| HIF-PHD-IN-5 |
|
|
|
|
| HIF1 agonist-1 |
|
|
|
99.11% |
| HIV-IN-7 |
|
|
|
|
| HNHA |
|
|
|
99.76% |
| HSP90-IN-30 |
|
|
|
|
| IDF-11774 |
|
|
|
99.30% |
| iGP-1 |
|
|
|
99.43% |
| Imdatifan |
|
|
|
|
| Iminostilbene-d10 |
|
|
|
|
| IOX2 |
|
|
|
98.02% |
| IOX2 sodium |
|
|
|
|
| IOX2-NH2 |
|
|
|
|
| IOX4 |
|
|
|
99.96% |
| IOX5 |
|
|
|
99.39% |
| ISM012-042 |
|
|
|
|
| Izilendustat |
|
|
|
98.01% |
| Izilendustat hydrochloride |
|
|
|
|
| JNJ-42041935 |
|
|
|
98.41% |
| JNJ-42905343 |
|
|
|
|
| JPHM-2-167 |
|
|
|
|
| Kamebakaurin |
|
|
|
99.64% |
| KC7F2 |
|
|
|
99.36% |
| KCN1 |
|
|
|
|
| KG-548 |
|
|
|
99.90% |
| KPLH1130 |
|
|
|
99.86% |
| KST012174 hydrochloride |
|
|
|
|
| L-Glutamine |
|
|
|
|
| L-Glutamine-1-13C |
|
|
|
98.0% |
| L-Glutamine-15N |
|
|
|
99.6% |
| L-Glutamine-15N-1 |
|
|
|
98.0% |
| L-Glutamine-15N2 |
|
|
|
99.95% |
| L-Glutamine-15N2,d5 |
|
|
|
|
| L-Glutamine-5-13C |
|
|
|
98.0% |
| L-Glutamine-d5 |
|
|
|
99.79% |
| L-Glutamine-13C5 |
|
|
|
99.93% |
| L-Glutamine-13C5,15N2 |
|
|
|
98.0% |
| L-Glutamine-13C5,15N2,d5 |
|
|
|
99.95% |
| Liensinine perchlorate |
|
|
|
99.67% |
| LW1564 |
|
|
|
|
| LW6 |
|
|
|
98.86% |
| M1001 |
|
|
|
99.51% |
| M1002 |
|
|
|
99.69% |
| mCPX |
|
|
|
|
| MDH1/2-IN-1 |
|
|
|
98.78% |
| Minocycline |
|
|
|
98.59% |
| Minocycline-d6 |
|
|
|
|
| Minocycline-d6 hydrochloride |
|
|
|
|
| Minocycline-d6 sulfate |
|
|
|
95.21% |
| Mitoquinol |
|
|
|
98.00% |
| MK-8617 |
|
|
|
99.92% |
| ML228 |
|
|
|
98.0% |
| ML228 analog |
|
|
|
|
| MO-2097 |
|
|
|
|
| Molidustat |
|
|
|
99.70% |
| Molidustat sodium |
|
|
|
|
| MPT0B098 |
|
|
|
|
| MS1129 |
|
|
|
|
| Multi-kinase-IN-8 |
|
|
|
|
| myo-Inositol trispyrophosphate hexa-triethylamine |
|
|
|
98.0% |
| myo-Inositol trispyrophosphate hexasodium |
|
|
|
95.0% |
| N-Oxalylglycine |
|
|
|
99.18% |
| Naphthofluorescein |
|
|
|
99.02% |
| Nastorazepide |
|
|
|
99.95% |
| Nastorazepide hemicalcium |
|
|
|
|
| NEO-811 |
|
|
|
|
| NF-κB-IN-19 |
|
|
|
|
| NF-κB/HIF-1α-IN-1 |
|
|
|
|
| NP1192 |
|
|
|
|
| NPAS3-IN-1 |
|
|
|
98.72% |
| NVP-DFF332 |
|
|
|
99.31% |
| O-Carboranylphenoxyacetanilide |
|
|
|
|
| Octyl-α-ketoglutarate |
|
|
|
99.9% |
| OHM1 |
|
|
|
|
| Oltipraz (GMP) |
|
|
|
|
| Oltipraz metabolite M2 |
|
|
|
|
| PHD-1 ligand-1 |
|
|
|
|
| PHD-1-IN-1 |
|
|
|
99.21% |
| PHD-1-IN-2 |
|
|
|
|
| PHD-1-IN-3 |
|
|
|
|
| PHD-1-IN-4 |
|
|
|
99.94% |
| PHD-IN-1 |
|
|
|
|
| PHD-IN-2 |
|
|
|
|
| PHD-IN-3 |
|
|
|
|
| PHD-IN-5 |
|
|
|
|
| PHD2-IN-1 |
|
|
|
|
| PHD2-IN-2 |
|
|
|
|
| PHD2-IN-3 |
|
|
|
|
| PHD2-IN-4 |
|
|
|
|
| PHD2-IN-5 |
|
|
|
|
| PHD2-IN-6 |
|
|
|
|
| PHD2/HDACs-IN-1 |
|
|
|
|
| PRLX-93936 |
|
|
|
98.31% |
| PRLX-93936 dihydrochloride |
|
|
|
99.83% |
| Prolyl Hydroxylase inhibitor 1 |
|
|
|
|
| PROTAC HIF-1α degrader-1 |
|
|
|
98.02% |
| PROTAC HIF-1α degrader-2 |
|
|
|
|
| Protectin D1 |
|
|
|
99.0% |
| PT-2385 |
|
|
|
99.95% |
| PT2399 |
|
|
|
99.96% |
| PX-478 |
|
|
|
99.58% |
| PX-478 (Standard) |
|
|
|
|
| PX-478 free base |
|
|
|
|
| RH01504 |
|
|
|
|
| SH-26 |
|
|
|
|
| SYP-5 |
|
|
|
99.21% |
| T7117 |
|
|
|
|
| TAT-cyclo-CLLFVY |
|
|
|
99.13% |
| TAT-cyclo-CLLFVY TFA |
|
|
|
|
| TAT-N24 |
|
|
|
|
| TC-S 7009 |
|
|
|
99.81% |
| Terpestacin |
|
|
|
|
| TFEB Decoy ODN sodium |
|
|
|
90.24% |
| Theasaponin E1 |
|
|
|
99.08% |
| THS-044 |
|
|
|
99.37% |
| TM6008 |
|
|
|
99.51% |
| TM6089 |
|
|
|
99.37% |
| TP0463518 |
|
|
|
99.25% |
| TRC160334 |
|
|
|
98.22% |
| TRC160334 sodium |
|
|
|
|
| Vadadustat |
|
|
|
99.70% |
| Vadadustat prodrug-1 |
|
|
|
|
| Vadadustat-13C6 |
|
|
|
|
| Verucopeptin |
|
|
|
97.0% |
| VH-298 |
|
|
|
99.54% |
| VHL-IN-1 |
|
|
|
99.84% |
| VU 0364439 |
|
|
|
99.42% |
| Zenidolol |
|
|
|
99.60% |
| ZG-2033 |
|
|
|
|
| ZG-2291 |
|
|
|
98.08% |
| ZG-2305 |
|
|
|
98.60% |
| ZG-2686 |
|
|
|
|
| Zifcasiran |
|
|
|
|
| Zifcasiran sodium |
|
|
|
|
| Zifcasiran sodium scrambled negative control |
|
|
|
|
| ZINC13466751 |
|
|
|
99.94% |
| ZnPc-O3-JQ1 |
|
|
|
|
| β,β-Dimethylacrylshikonin |
|
|
|
99.30% |
| Beta-Sitosterol (purity>98%) |
|
|
|
99.74% |
| Dencichine |
|
|
|
99.59% |
| Cephalomannine |
|
|
|
99.04% |
| Iminostilbene |
|
|
|
99.34% |
| Panaxadiol |
|
|
|
99.89% |
| Oroxylin A |
|
|
|
99.40% |
| Ethyl 3,4-dihydroxybenzoate |
|
|
|
99.96% |
| Deoxyshikonin |
|
|
|
99.83% |
| Deferoxamine |
|
|
|
99.57% |
| Dimethyl-bisphenol A |
|
|
|
99.78% |
| Acriflavine |
|
|
|
98.0% |
| Acriflavine hydrochloride |
|
|
|
98.0% |
| Oltipraz-d3 |
|
|
|
|
| Oltipraz |
|
|
|
99.71% |
| Pseudolaric Acid B |
|
|
|
98.67% |
| Asperosaponin VI |
|
|
|
99.62% |
| Pectolinarigenin |
|
|
|
99.98% |
| Moracin O |
|
|
|
99.98% |
| Moracin P |
|
|
|
99.62% |
| Amifostine |
|
|
|
99.95% |
| Amifostine trihydrate |
|
|
|
99.95% |
| Amifostine sodium |
|
|
|
|
| Chloramphenicol |
|
|
|
99.96% |
| Threo-Chloramphenicol-d6 |
|
|
|
|
| Mersalyl |
|
|
|
89.25% |
| Licoflavone A |
|
|
|
99.95% |
| Deferoxamine mesylate |
|
|
|
99.76% |
| Tilorone dihydrochloride |
|
|
|
99.29% |
| Glucosamine-13C,15N hydrochloride |
|
|
|
|
| Glucosamine-13C6,15N hydrochloride |
|
|
|
|
| Glucosamine-13C hydrochloride |
|
|
|
98.13% |
| Glucosamine-15N hydrochloride |
|
|
|
98.0% |
| Glucosamine-2-13C hydrochloride |
|
|
|
99% |
| Glucosamine-6-13C hydrochloride |
|
|
|
98.0% |
| Glucosamine hydrochloride |
|
|
|
98.0% |
| Minocycline hydrochloride |
|
|
|
99.71% |
| Dendrophenol |
|
|
|
99.93% |
| Glucosamine sulfate |
|
|
|
98.0% |
| Glucosamine sulfate sodium chloride |
|
|
|
|
| Glucosamine sulfate potassium chloride |
|
|
|
99.51% |
| Agnuside |
|
|
|
99.90% |
| Minocycline-d7 |
|
|
|
|
| Chlorogenic acid |
|
|
|
99.53% |
| Roxadustat |
|
|
|
99.92% |
| Roxadustat-d5 |
|
|
|
98.0% |
| Fenbendazole |
|
|
|
99.94% |
| Fenbendazole-d3 |
|
|
|
99.70% |
| Steppogenin |
|
|
|
99.49% |
| Liensinine |
|
|
|
99.97% |
| Liensinine Diperchlorate |
|
|
|
99.96% |
| Glucosamine |
|
|
|
98.0% |
| Cucurbitacin B |
|
|
|
99.81% |
| Caulerpin |
|
|
|
|
| Bavachinin |
|
|
|
99.95% |
| Streptonigrin |
|
|
|
99.9% |
| Albendazole |
|
|
|
99.05% |
| Cryptochlorogenic acid |
|
|
|
99.23% |